[1]Locationinpatent:experimentalpartHutinec,Antun;Rupcic,Renata;Ziher,Dinko;Smith,KirstenS.;Milhous,Wilbur;Ellis,William;Ohrt,Colin;Schoenfeld,ZrinkaIvezic[BioorganicandMedicinalChemistry,2011,vol.19,#5,p.1692-1701]
361392-21-4
1072945-98-2 | 2-Chloro-5-methoxypyridine-4-boronic acid | AA003BK0 | MFCD09972106
852526-08-0 | (3-Bromo-1-propyn-1-yl)cyclopropane | AA003BO7 | MFCD20623445
186498-24-8 | 4-Butyrylphenylboronic acid | AA003BSC | MFCD08701778
105379-24-6 | (1H-Benzo[d][1,2,3]triazol-1-yl)(di(pyrrolidin-1-yl)methylene)oxonium hexafluorophosphate(V) | AA003BWS | MFCD00191770
163927-31-9 | (R)-(-)-Dbd-py-ncs | AA003C0L | MFCD00671493
64960-75-4 | H-D-Asp(otbu)-oh | AA003C66 | MFCD00077101
84249-39-8 | (S)-(-)-2-(Alpha-methylbenzylamino)-5-nitropyridine | AA003CAK | MFCD21092079
4187-56-8 | (S)-1-(4-Chlorophenyl)ethanamine | AA003CG0 | MFCD00671640
499995-75-4 | Boc-(s)-3-amino-3-(3-methyl-phenyl)-propionic acid | AA003CKD | MFCD03427896
385404-09-1 | 1-(4-Bromophenylsulfonyl)-4-ethylpiperazine | AA003CPA | MFCD02656010